STEPHEN COX: Open Payments
NPI 1295915353 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,851 in 106 payments from 15 companies in 2025. Trend: 2023 $1,143 · 2024 $1,634 · 2025 $1,851
Food & beverage: $1,685Education: $166
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $430 |
| Janssen Biotech, Inc. | 17 | $311 |
| GENZYME CORPORATION | 15 | $278 |
| Galderma Laboratories, L.P. | 13 | $205 |
| Regeneron Healthcare Solutions, Inc. | 3 | $94 |
| Incyte Corporation | 4 | $85 |
| UCB, Inc. | 3 | $83 |
| Novartis Pharmaceuticals Corporation | 3 | $80 |
| PFIZER INC. | 4 | $68 |
| Lilly USA, LLC | 2 | $61 |
Products named: DUPIXENT, SKYRIZI, TREMFYA, NEMLUVIO, OPZELURA, Bimzelx, COSENTYX, CIBINQO.
Industry payments across AZ — which companies pay providers there.
